Clinical Trial Update: A Crossover Study to Evaluate the Efficacy of Simvastatin in Elevating HDL-C Levels in Patients With Type 2 Diabetes (0733-216)(COMPLETED) [Phase 3]

View source ↗

Summary

A completed Phase 3 crossover study evaluating whether simvastatin elevates HDL cholesterol in patients with type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Organon and Co | Conditions: HDL Cholesterol | Phase 3 | Status: COMPLETED